Post-approval studies (Phase 4)Study completedNCT00731224
What this trial is testing
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 380